Pharmaceutical Excipient for Taste Masking Market
Pharmaceutical Excipient for Taste Masking Market Study by Natural, Artificial, Nutritive, Non-nutritive, and Polyols for Pharmaceuticals, Nutraceuticals, and Contract Manufacturing from 2024 to 2034
Analysis of Pharmaceutical Excipient for Taste Masking Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Pharmaceutical Excipient for Taste Masking Market Outlook (2024 to 2034)
The global pharmaceutical excipient for taste masking market size is set to be valued at US$ 972.9 million in 2024 and has been forecasted to expand at a CAGR of 5% to reach US$ 1.58 billion by the end of 2034.
It has always been a challenging task for patients to consume bitter medicines while they are sick. In many instances, patients refuse to take medicines due to their unpleasant taste. This is a major problem drug manufacturers have to face. Pharmaceutical companies have introduced excipients to address this issue of taste masking. These agents effectively diminish the bitter taste, enhancing the overall palatability for patients, thus promoting faster healing. The rising popularity of these excipients in the medical industry stems from their considerable success and high demand among end users.
Taste stands as a pivotal factor in ensuring patient compliance. The presence of an unpleasant taste poses a significant challenge in formulating certain medications. Ensuring oral delivery of bitter medications with an acceptable level of palatability is a crucial consideration for healthcare providers, especially when treating young patients. Several oral medications, as well as food and beverage items, contain bitter-tasting ingredients, necessitating the use of taste-masking agents. Consequently, pharmaceutical formulations with pleasant tastes are preferred over competitors' products, leading to enhanced patient compliance, therapeutic efficacy, and increased sales and profits for the company.
Key Market Growth Drivers
- Children desire medicines with a more pleasant taste, making them a primary target for taste-masking agent manufacturers. Pharmaceutical companies target regions with higher pediatric patient numbers to exponentially boost their sales.
- Spices, herbs, and hot peppers are excellent natural flavor enhancers. These organic compounds, commonly used to enhance flavors, also serve as maskers. When opting for natural substitutes, it is vital to strike a delicate balance between the inherent flavor of the chosen enhancer or masking agent and the overall taste.
- Mitigating bitterness and inhibiting it are essential aspects of an effective oral dosage form. Significant progress in taste-masking compositions has been made in recent years. Established methods for reducing and inhibiting bitterness have improved the palatability of these formulations. The widespread adoption of oral medications as alternatives to traditionally injectable peptides may increase if bitterness can be partially eliminated. Recent years have witnessed notable advancements in developing bitterness-free, flavor-neutral, and taste-masked compositions.
| Report Attribute | Detail |
|---|---|
| Pharmaceutical Excipient for Taste Masking Market Size (2024E) | US$ 972.9 Million |
| Forecasted Market Value (2034F) | US$ 1.58 Billion |
| Global Market Growth Rate (2024 to 2034) | 5% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 4.1% CAGR |
| China Market Value (2034F) | US$ 242 Million |
| North America Market Share (2024E) | 29.2% |
| East Asia Market Share (2034F) | 21.5% |
| Key Companies Profiled | AbbVie; NextPharma; Patheon; Lonza; Quotient; Fertin Pharma; Sciences and Senopsys; Catalent; Adare Pharmaceutical Inc.; SPI Pharma Inc.; Asahi Kasei Corporation; Rochem International Inc.; GPT Pharmaceuticals Pvt. Ltd.; DuPont de Numours Inc.; Dow Pharma Solutions. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Use of Taste-Masking Agents in Pharmaceuticals?
“Enhanced Patient Adherence Due to Improved Taste and Odor”
Taste and smell can distinguish the flavor of any substance. Any substance with a bitter taste struggles to gain widespread acceptance. Therefore, for patients such as the elderly and toddlers to orally consume traditional bitter drugs, taste masking agents are now necessary. This is a major factor driving the pharmaceutical excipient for taste masking market growth.
Pharmaceutical excipients for taste masking play a crucial role in the final formulation of oral drugs unless the compounds are tasteless or have an unpleasant taste. These excipients help impart a pleasant taste to many final prescription formulations, potentially alleviating nausea caused by the taste of the drug.
Use of various excipients for sweetening, ranging from synthetic to natural, has provided companies with the necessary ability to compete in the market for flavor masking in terms of price, availability, and convenience.
Chronic and lifestyle-related illnesses are increasingly prevalent worldwide. Major chronic illnesses include diabetes, cardiovascular disorders, cancer, obesity, osteoporosis, and pulmonary ailments. Lifestyle-related factors such as smoking, lack of exercise, and unhealthy eating habits all contribute to the growing demand for medication.
Which Factor Has the Potential to Shrink Profits of Suppliers?
“Concerns over Adverse Patient Outcomes Resulting from Mixing of Excipients”
Processes for licensing generic pharmaceuticals are uniform globally, with minor differences in developing nations. This is because worldwide, bioequivalence (BE) studies are not mandatory for generic drug approval. Healthcare experts argue that governments need to ensure consistent quality across all generic pharmaceuticals.
Lack of confidence in generic pharmaceuticals, particularly among physicians and patients, is often attributed to lenient regulatory standards regarding the number of generics available and permissible contaminants. Regulation of excipient manufacturing and distribution is currently a pressing concern for both authorities and drug manufacturers, as mixing excipients has led to adverse patient outcomes. The emergence of new excipients and delivery systems has underscored the importance of maintaining greater control over the supply and quality of pharmaceutical excipients, especially concerning in vivo performance.
Given the critical role of excipients in pharmaceutical formulations, excipient suppliers must meet stringent industry quality standards, and the pharmaceutical sector as a whole must collaborate to ensure product safety throughout the supply chain. Consequently, the increase in regulatory requirements for pharmaceutical and excipient licensing could potentially impact the pharmaceutical excipient market for taste masking market size.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
The market in Japan is forecasted to expand at a CAGR of 4.8%. The country is evaluated to occupy a pharmaceutical excipient for taste masking market share of 26.2% in East Asia by the end of 2034.
What is Making the United States a Profit Hive in the North American Region?
“Increased Demand for Functional Excipients and Focus on Developing Improved Agents”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 241.6 Million |
| Growth Rate (2024 to 2034) | 5.2% CAGR |
| Projected Value (2034F) | US$ 402.1 Million |
The pharmaceutical sector’s steady expansion, increased demand for functional excipients, presence of major market players, and technological advancements in the United States are projected to greatly influence market growth over the forecast period. Development of advanced excipients is also contributing to market growth.
- For instance, Apisolex was introduced in the United States in May 2022 by Lubrizol Life Science (LLS) Health, a global leader in pharmaceutical innovation. This new excipient enhances solubility in parenteral medication formulations.
Why Should Manufacturers Keep a Close Eye on China for Potential Opportunities?
“Widespread Use of Chitosan for Taste Modification in Chinese Medicine”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 143 Million |
| Growth Rate (2024 to 2034) | 5.4% CAGR |
| Projected Value (2034F) | US$ 242 Million |
The taste-modifying role of chitosan in bitter alkaloid and flavonoid glycoside medications has roots in traditional Chinese medicine. This taste-modifying technique can also improve the unpleasant taste of TCMs. This flavor-modification method could offer fresh perspectives on masking the taste of TCM, especially in certain TCM oral formulations for children, potentially enhancing pediatric patients' adherence.
Category-wise Insights
Based on end user, nutraceuticals are estimated to hold a market share of 10.3% in 2024, and their sales are calculated to increase at a CAGR of 4.3% from 2024 to 2034.
What Role Do Artificial Agents Play in Masking Bitter Tastes in Medicines?
“Efficiency and Speed of Artificial Masking Agents in Concealing Bitter Taste”
| Attribute | Artificial |
|---|---|
| Segment Value (2024E) | US$ 338.6 Million |
| Growth Rate (2024 to 2034) | 5.3% CAGR |
| Projected Value (2034F) | US$ 566.7 Million |
Artificial masking agents are proven to be quicker and easier to mask or hide the bitter taste in medicine or any food. Drug suppliers often opt for artificial masking agents over natural agents due to this factor, which is a critical pharmaceutical excipient for taste masking market trend.
Why Do Manufacturers Prefer the Coating for Producing Masking Agents?
“Coating Technique Reduces Need for Extensive Time and Machinery”
| Attribute | Coating |
|---|---|
| Segment Value (2024E) | US$ 321.4 Million |
| Growth Rate (2024 to 2034) | 5.3% CAGR |
| Projected Value (2034F) | US$ 541 Million |
Compared to other techniques, coating is much more prevalent in the industry as coating does not require much time and machinery. Thus, most of the manufacturers go with the idea of coating while manufacturing masking agents.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
To enhance their market share, key players in the pharmaceutical excipient for taste masking market are focusing on creating new platforms and a variety of taste-masking technologies. These include stimuli-responsive drug delivery systems, which employ pH- and ion-sensitive polymers to mask the harsh taste of medications and adapt themselves to the evolving market trends such as sustained release excipients and cellulose derivative excipients.
- In March 2022, CD Formulation offered customized solutions for greater bioavailability excipients to solve the issue of poor bioavailability, which has long been a challenge in pharmaceutical manufacturing.
- In October 2021, Beneo introduced galenIQ 721. The filler binder improves the flavor and stability of effervescent tablets and powders. It is a non-hygroscopic, water-soluble, and quickly compressible excipient that provides excellent content consistency and production efficiency in effervescent applications.
Fact.MR provides detailed information about the price points of manufacturers of key pharmaceutical excipients for taste masking positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
Key Segments of Pharmaceutical Excipient for Taste Masking Market Research
-
By Excipient :
- Natural
- Artificial
- Nutritive
- Non-nutritive
- Polyols
- Others
-
By Technique :
- Hot Melt Extrusion
- Microencapsulation
- Coating
- Organoleptic Methods
- Others
-
By Usage :
- Solid Dosage Forms
- Tablets
- Granules
- Capsules
- Liquid Dosage Forms
- Solid Dosage Forms
-
By End Use :
- Pharmaceuticals
- Nutraceuticals
- Contract Manufacturing Organizations
-
By Region :
- North America
- Latin America
- Eastern Europe
- Western Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Excipient 6.2. Technique 6.3. Usage 6.4. End Use 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Excipient 7.1. Natural 7.2. Artificial 7.3. Nutritive 7.4. Non-nutritive 7.5. Polyols 7.6. Others 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Technique 8.1. Hot Melt Extrusion 8.2. Microencapsulation 8.3. Coating 8.4. Organoleptic Methods 8.5. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Usage 9.1. Solid Dosage Forms 9.2. Liquid Dosage Forms 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End Use 10.1. Pharmaceuticals 10.2. Nutraceuticals 10.3. Contract Manufacturing Organizations 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 11.1. North America 11.2. Latin America 11.3. Western Europe 11.4. Eastern Europe 11.5. East Asia 11.6. South Asia & Pacific 11.7. Middle East & Africa 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. Sales Forecast 2024 to 2034 by Excipient, Technique, Usage, End Use, and Region for 30 Countries 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 21. Company Profile 21.1. AbbVie 21.2. NextPharma 21.3. Patheon 21.4. Lonza 21.5. Quotient 21.6. Fertin Pharma 21.7. Sciences and Senopsys 21.8. Catalent 21.9. Adare Pharmaceutical Inc. 21.10. SPI Pharma Inc. 21.11. Asahi Kasei Corporation 21.12. Rochem International Inc. 21.13. GPT Pharmaceuticals Pvt. Ltd. 21.14. DuPont de Numours Inc. 21.15. Dow Pharma Solutions 22. Assumptions and Acronyms Used 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 37: Latin America Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 38: Latin America Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 40: Latin America Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 41: Latin America Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 42: Latin America Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 46: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: Western Europe Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 50: Western Europe Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 51: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 52: Western Europe Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 53: Western Europe Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 54: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 55: Western Europe Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 56: Western Europe Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 57: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 58: Western Europe Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 59: Western Europe Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 60: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 61: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 62: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: Eastern Europe Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 65: Eastern Europe Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 66: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 67: Eastern Europe Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 68: Eastern Europe Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 69: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 70: Eastern Europe Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 71: Eastern Europe Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 72: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 73: Eastern Europe Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 74: Eastern Europe Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 75: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 76: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 77: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 78: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 79: East Asia Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 80: East Asia Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 81: East Asia Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 82: East Asia Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 83: East Asia Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 84: East Asia Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 85: East Asia Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 86: East Asia Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 87: East Asia Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 88: East Asia Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 89: East Asia Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 90: East Asia Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 91: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 92: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 93: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 94: South Asia & Pacific Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 95: South Asia & Pacific Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 96: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 97: South Asia & Pacific Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 98: South Asia & Pacific Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 99: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 100: South Asia & Pacific Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 101: South Asia & Pacific Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 102: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 103: South Asia & Pacific Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 104: South Asia & Pacific Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 105: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 106: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 107: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 108: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 109: MEA Market Value (US$ Mn) Analysis, by Excipient, 2019 to 2023
Table 110: MEA Market Value (US$ Mn) Analysis, by Excipient, 2024 to 2034
Table 111: MEA Market Value (US$ Mn) Opportunity Analysis, by Excipient, 2024 to 2034
Table 112: MEA Market Value (US$ Mn) Analysis, by Technique, 2019 to 2023
Table 113: MEA Market Value (US$ Mn) Analysis, by Technique, 2024 to 2034
Table 114: MEA Market Value (US$ Mn) Opportunity Analysis, by Technique, 2024 to 2034
Table 115: MEA Market Value (US$ Mn) Analysis, by Usage, 2019 to 2023
Table 116: MEA Market Value (US$ Mn) Analysis, by Usage, 2024 to 2034
Table 117: MEA Market Value (US$ Mn) Opportunity Analysis, by Usage, 2024 to 2034
Table 118: MEA Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 119: MEA Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 120: MEA Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 20: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 21: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 22: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 23: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 24: North America Market Share Analysis by Country, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 39: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 40: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 41: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 42: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 43: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 49: Latin America Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 50: Latin America Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 51: Latin America Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 52: Latin America Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 53: Latin America Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 54: Latin America Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 55: Latin America Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 58: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 59: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 60: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 61: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 62: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 63: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 64: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Western Europe Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 66: Western Europe Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 67: Western Europe Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 68: Western Europe Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 69: Western Europe Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 70: Western Europe Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 71: Western Europe Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 72: Western Europe Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 73: Western Europe Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 74: Western Europe Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 75: Western Europe Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 76: Western Europe Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 77: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 78: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 79: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 80: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 81: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 82: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 83: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 84: Eastern Europe Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 85: Eastern Europe Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 86: Eastern Europe Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 87: Eastern Europe Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 88: Eastern Europe Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 89: Eastern Europe Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 90: Eastern Europe Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 91: Eastern Europe Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 92: Eastern Europe Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 93: Eastern Europe Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 94: Eastern Europe Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 95: Eastern Europe Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 96: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 97: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 98: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 99: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 100: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 101: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 102: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 103: East Asia Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 104: East Asia Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 105: East Asia Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 106: East Asia Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 107: East Asia Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 108: East Asia Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 109: East Asia Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 110: East Asia Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 111: East Asia Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 112: East Asia Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 113: East Asia Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 114: East Asia Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 115: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 116: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 117: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 118: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 119: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 120: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 121: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 122: South Asia & Pacific Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 123: South Asia & Pacific Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 124: South Asia & Pacific Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 125: South Asia & Pacific Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 126: South Asia & Pacific Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 127: South Asia & Pacific Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 128: South Asia & Pacific Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 129: South Asia & Pacific Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 130: South Asia & Pacific Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 131: South Asia & Pacific Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 132: South Asia & Pacific Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 133: South Asia & Pacific Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 134: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 135: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 136: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 137: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 138: MEA Market Share Analysis by Country, 2024 & 2034
Figure 139: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 140: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 141: MEA Market Share and BPS Analysis by Excipient, 2024 & 2034
Figure 142: MEA Market Y-o-Y Growth Projections by Excipient, 2024 to 2034
Figure 143: MEA Market Attractiveness Analysis by Excipient, 2024 to 2034
Figure 144: MEA Market Share and BPS Analysis by Technique, 2024 & 2034
Figure 145: MEA Market Y-o-Y Growth Projections by Technique, 2024 to 2034
Figure 146: MEA Market Attractiveness Analysis by Technique, 2024 to 2034
Figure 147: MEA Market Share and BPS Analysis by Usage, 2024 & 2034
Figure 148: MEA Market Y-o-Y Growth Projections by Usage, 2024 to 2034
Figure 149: MEA Market Attractiveness Analysis by Usage, 2024 to 2034
Figure 150: MEA Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 151: MEA Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 152: MEA Market Attractiveness Analysis by End Use, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the pharmaceutical excipient for taste masking market in 2024?
The global market for pharmaceutical excipients for taste masking is estimated at US$ 972.9 million in 2024.
What are the forecasted sales for taste masking excipients by 2034?
Worldwide sales of pharmaceutical excipients for taste masking are projected to reach US$ 1.58 billion by 2034.
What is the demand growth projection for the global market?
Worldwide demand for pharmaceutical excipients for taste masking is forecasted to rise at a CAGR of 5% from 2024 to 2034.
At what rate is the South Korean market forecasted to expand?
The market in South Korea is projected to expand at a CAGR of 4.9% through 2034.
Who are the leading producers of masking taste excipients?
Leading companies in the market are AbbVie, NextPharma, and Patheon.
What is the projection for the market in East Asia?
The market in East Asia is projected to generate revenue worth US$ 342 million by 2034.
Which type of masking agents are in higher demand?
Revenue from the sales of artificial taste masking excipients is projected to reach US$ 566.7 million by 2034.
Pharmaceutical Excipient for Taste Masking Market